Bill > SB0610

This bill requires TennCare (Tennessee's Medicaid program) to provide coverage for continuous glucose monitors (CGMs), which are devices that automatically track blood sugar levels, for certain eligible enrollees. The bill specifies that CGM coverage will be mandated for patients with Type 1 diabetes, gestational diabetes, a history of problematic hypoglycemia, or those requiring insulin. For patients with Type 2 diabetes, coverage is available if they meet specific medical criteria, such as having a hemoglobin A1C greater than 7%, experiencing frequent hypoglycemia, having hypoglycemic unawareness, experiencing dawn phenomenon with high fasting blood sugars, or having a history of emergency room visits or hospitalizations related to diabetes complications. The CGM must be prescribed by an endocrinologist or a healthcare practitioner experienced in diabetes management who can document that the patient meets the specified eligibility requirements. The bill will take effect on January 1, 2026, and aims to improve diabetes management and patient care by increasing access to continuous glucose monitoring technology for TennCare enrollees.

Business and Industry

https://wapp.capitol.tn.gov/apps/Billinfo/default.aspx?BillNumber=SB0610&ga=114